ziprasidone: Clinical Trials

6 trials of ziprasidone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 terminated, 1 unknown. 6 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 3, Active not recruiting 1, Terminated 1, Unknown 1
Phase 21Unknown 1

Follow ziprasidone: new trials by email Literature Review of ziprasidone trials Research Report on ziprasidone

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gene-by-Stress Interactions in Intervention Studies Significance
Ziprasidone, Lorcaserin, Placebo Oral Tablet - Cardiovascular Diseases
Phase 1TerminatedDuke University72018-05-242020-02-17
Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia
Ziprasidone, Olanzapine, Placebo Comparator - Schizophrenia
Phase 1Active not recruitingUniversity of Arizona242017-11-202026-07-08
The Role of miR-30 Family Dysregulation in Response to Antipsychotic Treatment
Risperidone, Olanzapine, Quetiapine - Schizophrenia
Phase 1 / Phase 2UnknownShanxi Medical University2002013-01-012016-01-08
Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules
ziprasidone, B16 Fasted, B16 Fed - Healthy
Phase 1CompletedPfizer's Upjohn has merged with Mylan to form Viatris Inc.112009-01-012021-02-21
Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg of Dr. Reddy's Under Fed Conditions
Ziprasidone Hydrochloride - Healthy
Phase 1CompletedDr. Reddy's Laboratories Limited382004-11-012012-04-20
Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions
Ziprasidone Hydrochloride - Healthy
Phase 1CompletedDr. Reddy's Laboratories Limited562004-11-012012-04-20

Conditions studied

Schizophrenia (3)  ·  Cardiovascular Diseases (1)  ·  Psychotic Disorders (1)

Sponsors

Dr. Reddy's Laboratories Limited (2)  ·  Duke University (1)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1)  ·  Shanxi Medical University (1)  ·  University of Arizona (1)

Countries

United States (5)  ·  China (1)

Top investigators

Antonio R. Pizarro, MD (2)  ·  Amelia Gallitano, MD,PhD (1)  ·  William E Kraus, MD (1)  ·  Yong Xu, Doctor (1)

NIH funding

P01HL036587 (1)